myo-Inositol restores the inflammation-induced down-regulation of taurine transport by the murine macrophage cell line, RAW 264.7

Ha Won Kim, Jung Hyun Kim, Hye Suk An, Kun Koo Park, Byong Kak Kim, Taesun Park

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The role of myo-inositol in the regulation of taurine transport in activated murine macrophage cell line, RAW 264.7, was studied. Challenge of RAW 264.7 murine macrophages for 24 hr with phorbol ester 12-myristate 13-acetate (PMA) (10 ng/ml), a PKC activator, resulted in a 62% decrease in taurine transport activity. Among the various monosaccharides (1 mM) tested in the presence of PMA, myo-inositol was most effective in restoring the PMA-induced down-regulation of taurine transport in murine macrophages (82% increase compared to the value for cells treated with PMA Alone, p < 0.01). The protective role of myo-inositol against stress-induced down-regulation of taurine transport by macrophages was further investigated in conditions mimicking bacterial infection, inflammation, and immune-suppressed circumstances. A challenge of murine macrophages with lipopolysaccharide (LPS) (0.1 and 10 μg/ml) resulted in a 60% decrease in taurine transport activity compared to the value for untreated control cells (p < 0.01). When cells were co-treated with myo-inositol (100 nM ∼ 10 mM) in the presence of LPS for 24 hrs, taurine transport activity increased in a dose-dependent manner compared to the value for cells treated with LPS only. Taurine transport activity in cells treated with LPS (10 μg/ml) plus interferon-gamma (IFN-γ) (150 unit/ml) for 24 hrs was 13% of the value for untreated control cells (p < 0.01). Again, this inflammation-induced down-regulation of taurine transport activity was completely antagonized with co-administration of 100 nM or higher levels of myo-inositol in the culture medium. Similarly, myo-inositol effectively restored the taurine transport activity suppressed by cyclosporin A (0.5 and 50 nM) in murine macrophages (p < 0.01). From these results, myo-inositol appears to be a common accelerator of taurine transport by murine macrophages in diverse conditions of down-regulated taurine transport.

Original languageEnglish
Pages (from-to)2477-2489
Number of pages13
JournalLife Sciences
Volume73
Issue number19
DOIs
Publication statusPublished - 2003 Sep 26

Fingerprint

Macrophages
Taurine
Inositol
Down-Regulation
Cells
Inflammation
Myristic Acid
Phorbol Esters
Lipopolysaccharides
Acetates
RAW 264.7 Cells
Monosaccharides
Bacterial Infections
Cyclosporine
Interferon-gamma
Particle accelerators
Culture Media

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Kim, Ha Won ; Kim, Jung Hyun ; An, Hye Suk ; Park, Kun Koo ; Kim, Byong Kak ; Park, Taesun. / myo-Inositol restores the inflammation-induced down-regulation of taurine transport by the murine macrophage cell line, RAW 264.7. In: Life Sciences. 2003 ; Vol. 73, No. 19. pp. 2477-2489.
@article{a7c2aad1fe614e17816bb2ffe51e607e,
title = "myo-Inositol restores the inflammation-induced down-regulation of taurine transport by the murine macrophage cell line, RAW 264.7",
abstract = "The role of myo-inositol in the regulation of taurine transport in activated murine macrophage cell line, RAW 264.7, was studied. Challenge of RAW 264.7 murine macrophages for 24 hr with phorbol ester 12-myristate 13-acetate (PMA) (10 ng/ml), a PKC activator, resulted in a 62{\%} decrease in taurine transport activity. Among the various monosaccharides (1 mM) tested in the presence of PMA, myo-inositol was most effective in restoring the PMA-induced down-regulation of taurine transport in murine macrophages (82{\%} increase compared to the value for cells treated with PMA Alone, p < 0.01). The protective role of myo-inositol against stress-induced down-regulation of taurine transport by macrophages was further investigated in conditions mimicking bacterial infection, inflammation, and immune-suppressed circumstances. A challenge of murine macrophages with lipopolysaccharide (LPS) (0.1 and 10 μg/ml) resulted in a 60{\%} decrease in taurine transport activity compared to the value for untreated control cells (p < 0.01). When cells were co-treated with myo-inositol (100 nM ∼ 10 mM) in the presence of LPS for 24 hrs, taurine transport activity increased in a dose-dependent manner compared to the value for cells treated with LPS only. Taurine transport activity in cells treated with LPS (10 μg/ml) plus interferon-gamma (IFN-γ) (150 unit/ml) for 24 hrs was 13{\%} of the value for untreated control cells (p < 0.01). Again, this inflammation-induced down-regulation of taurine transport activity was completely antagonized with co-administration of 100 nM or higher levels of myo-inositol in the culture medium. Similarly, myo-inositol effectively restored the taurine transport activity suppressed by cyclosporin A (0.5 and 50 nM) in murine macrophages (p < 0.01). From these results, myo-inositol appears to be a common accelerator of taurine transport by murine macrophages in diverse conditions of down-regulated taurine transport.",
author = "Kim, {Ha Won} and Kim, {Jung Hyun} and An, {Hye Suk} and Park, {Kun Koo} and Kim, {Byong Kak} and Taesun Park",
year = "2003",
month = "9",
day = "26",
doi = "10.1016/S0024-3205(03)00656-8",
language = "English",
volume = "73",
pages = "2477--2489",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "19",

}

myo-Inositol restores the inflammation-induced down-regulation of taurine transport by the murine macrophage cell line, RAW 264.7. / Kim, Ha Won; Kim, Jung Hyun; An, Hye Suk; Park, Kun Koo; Kim, Byong Kak; Park, Taesun.

In: Life Sciences, Vol. 73, No. 19, 26.09.2003, p. 2477-2489.

Research output: Contribution to journalArticle

TY - JOUR

T1 - myo-Inositol restores the inflammation-induced down-regulation of taurine transport by the murine macrophage cell line, RAW 264.7

AU - Kim, Ha Won

AU - Kim, Jung Hyun

AU - An, Hye Suk

AU - Park, Kun Koo

AU - Kim, Byong Kak

AU - Park, Taesun

PY - 2003/9/26

Y1 - 2003/9/26

N2 - The role of myo-inositol in the regulation of taurine transport in activated murine macrophage cell line, RAW 264.7, was studied. Challenge of RAW 264.7 murine macrophages for 24 hr with phorbol ester 12-myristate 13-acetate (PMA) (10 ng/ml), a PKC activator, resulted in a 62% decrease in taurine transport activity. Among the various monosaccharides (1 mM) tested in the presence of PMA, myo-inositol was most effective in restoring the PMA-induced down-regulation of taurine transport in murine macrophages (82% increase compared to the value for cells treated with PMA Alone, p < 0.01). The protective role of myo-inositol against stress-induced down-regulation of taurine transport by macrophages was further investigated in conditions mimicking bacterial infection, inflammation, and immune-suppressed circumstances. A challenge of murine macrophages with lipopolysaccharide (LPS) (0.1 and 10 μg/ml) resulted in a 60% decrease in taurine transport activity compared to the value for untreated control cells (p < 0.01). When cells were co-treated with myo-inositol (100 nM ∼ 10 mM) in the presence of LPS for 24 hrs, taurine transport activity increased in a dose-dependent manner compared to the value for cells treated with LPS only. Taurine transport activity in cells treated with LPS (10 μg/ml) plus interferon-gamma (IFN-γ) (150 unit/ml) for 24 hrs was 13% of the value for untreated control cells (p < 0.01). Again, this inflammation-induced down-regulation of taurine transport activity was completely antagonized with co-administration of 100 nM or higher levels of myo-inositol in the culture medium. Similarly, myo-inositol effectively restored the taurine transport activity suppressed by cyclosporin A (0.5 and 50 nM) in murine macrophages (p < 0.01). From these results, myo-inositol appears to be a common accelerator of taurine transport by murine macrophages in diverse conditions of down-regulated taurine transport.

AB - The role of myo-inositol in the regulation of taurine transport in activated murine macrophage cell line, RAW 264.7, was studied. Challenge of RAW 264.7 murine macrophages for 24 hr with phorbol ester 12-myristate 13-acetate (PMA) (10 ng/ml), a PKC activator, resulted in a 62% decrease in taurine transport activity. Among the various monosaccharides (1 mM) tested in the presence of PMA, myo-inositol was most effective in restoring the PMA-induced down-regulation of taurine transport in murine macrophages (82% increase compared to the value for cells treated with PMA Alone, p < 0.01). The protective role of myo-inositol against stress-induced down-regulation of taurine transport by macrophages was further investigated in conditions mimicking bacterial infection, inflammation, and immune-suppressed circumstances. A challenge of murine macrophages with lipopolysaccharide (LPS) (0.1 and 10 μg/ml) resulted in a 60% decrease in taurine transport activity compared to the value for untreated control cells (p < 0.01). When cells were co-treated with myo-inositol (100 nM ∼ 10 mM) in the presence of LPS for 24 hrs, taurine transport activity increased in a dose-dependent manner compared to the value for cells treated with LPS only. Taurine transport activity in cells treated with LPS (10 μg/ml) plus interferon-gamma (IFN-γ) (150 unit/ml) for 24 hrs was 13% of the value for untreated control cells (p < 0.01). Again, this inflammation-induced down-regulation of taurine transport activity was completely antagonized with co-administration of 100 nM or higher levels of myo-inositol in the culture medium. Similarly, myo-inositol effectively restored the taurine transport activity suppressed by cyclosporin A (0.5 and 50 nM) in murine macrophages (p < 0.01). From these results, myo-inositol appears to be a common accelerator of taurine transport by murine macrophages in diverse conditions of down-regulated taurine transport.

UR - http://www.scopus.com/inward/record.url?scp=0042280352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042280352&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(03)00656-8

DO - 10.1016/S0024-3205(03)00656-8

M3 - Article

VL - 73

SP - 2477

EP - 2489

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 19

ER -